Lumature Wealth Partners’s Biogen BIIB Stock Holding History

Lumature Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.12K	Hold	32	–	–	0.01%	317
2023 Q1	$8.9K	Sell	32 -30	-48%	-$8.3K	0.01%	310
2022 Q4	$17.2K	Hold	62	–	–	0.01%	279
2022 Q3	$17K	Sell	62 -77	-55%	-$16.4K	0.01%	291
2022 Q2	$28K	Sell	139 -5,548	-98%	-$1.13M	0.01%	266
2022 Q1	$1.2M	Buy	5,687 +2,055	+57%	+$447K	0.48%	48
2021 Q4	$871K	Buy	3,632 +374	+11%	+$96.2K	0.34%	69
2021 Q3	$922K	Buy	3,258 +310	+11%	+$102K	0.38%	60
2021 Q2	$1.02M	Buy	2,948 +85	+3%	+$25.8K	0.42%	49
2021 Q1	$801K	Buy	2,863 +1,377	+93%	+$371K	0.42%	48
2020 Q4	$364K	Buy	+1,486	New	+$383K	0.34%	88

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lumature Wealth Partners's BIIB Position: Q2 2023 in Review

Lumature Wealth Partners held its Biogen (BIIB) position steady in Q2 2023 at 32 shares worth $9.12K. The position accounts for 0.01% of the portfolio, ranked #317.

Lumature Wealth Partners first reported a position in BIIB in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.2M in Q1 2022. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Lumature Wealth Partners held 32 shares of Biogen worth $9.12K as of Q2 2023.
Lumature Wealth Partners left its Biogen share count unchanged in Q2 2023.
Biogen made up 0.01% of Lumature Wealth Partners's portfolio in Q2 2023, its #317 holding.
Lumature Wealth Partners first reported a position in Biogen in Q4 2020 and has held it in 11 quarters since.
Lumature Wealth Partners's Biogen position peaked at $1.2M in Q1 2022.
1,009 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.